SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $462,000 | -63.2% | 29,636 | -55.2% | 0.73% | +671.6% |
| Q1 2018 | $1,256,000 | -92.1% | 66,111 | -93.2% | 0.10% | -91.8% |
| Q4 2017 | $15,844,000 | +1.4% | 966,128 | -7.2% | 1.16% | +9.4% |
| Q3 2017 | $15,622,000 | +349.7% | 1,041,478 | +163.7% | 1.06% | +320.6% |
| Q2 2017 | $3,474,000 | – | 394,877 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |